{"effective_time":"20171211","id":"122ce0bd-72ac-4608-8ef4-7a7f94afdeeb","openfda":{},"package_label_principal_display_panel":["Principal Display Panel NDC 0173-0846-08 Tafinlar ® (Dabrafenib) Capsules 50 mg Rx only 120 Capsules Federal Law requires dispensing of TAFINLAR ® with the Medication Guide provided with this bottle. Each capsule contains 59.25 mg dabrafenib mesylate equivalent to 50 mg dabrafenib. Dosage: See accompanying prescribing information. Store at 25°C (77°F); excursions permitted 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Do not use if printed safety seal under cap is broken or missing. GlaxoSmithKline RTP, NC 27709 10000000124205 Rev. 3/14 Tafinlar 50mg 120 count label","Principal Display Panel NDC 0173-0847-08 Tafinlar ® (Dabrafenib) Capsules 75 mg Rx only 120 Capsules Federal Law requires dispensing of TAFINLAR ® with the Medication Guide provided with this bottle. Each capsule contains 88.88 mg dabrafenib mesylate equivalent to 75 mg dabrafenib. Dosage: See accompanying prescribing information. Store at 25°C (77°F); excursions permitted 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Do not use if printed safety seal under cap is broken or missing. GlaxoSmithKline RTP, NC 27709 10000000124207 Rev. 3/14 Tafinlar 75mg 120 count label"],"set_id":"c6e1972e-4cbd-4f07-8fe4-5b4324428b0d","spl_product_data_elements":["Tafinlar dabrafenib DABRAFENIB MESYLATE DABRAFENIB SILICON DIOXIDE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE HYPROMELLOSE, UNSPECIFIED FERRIC OXIDE RED TITANIUM DIOXIDE GSTEW;50mg Tafinlar dabrafenib DABRAFENIB MESYLATE DABRAFENIB SILICON DIOXIDE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE HYPROMELLOSE, UNSPECIFIED FERRIC OXIDE RED TITANIUM DIOXIDE GSLHF;75mg"],"version":"2"}